Moncef Slaoui - Jun 19, 2024 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Role
Director
Signature
/s/ Grant Levine, attorney-in-fact
Stock symbol
ARCT
Transactions as of
Jun 19, 2024
Transactions value $
$0
Form type
4
Date filed
6/21/2024, 09:30 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARCT Stock option (right to buy) Award $0 +15K $0.00 15K Jun 19, 2024 Common Stock 15K $25.96 Direct F1
transaction ARCT Stock option (right to buy) Award $0 +14.8K $0.00 14.8K Jun 19, 2024 Common Stock 14.8K $25.96 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares underlying the option vest monthly over a two year period from the date of grant. This represents the initial grant to the Reporting Person as a member of the Board of Directors.
F2 Shares underlying the option vest monthly over a one year period from the date of grant. This represents the annual grant to the Reporting Person as a member of the Board, prorated based on the date the Reporting Person was appointed to the Board.